Autopsy report · NCT02474407
Bioavailability, Safety and Tolerability of Diazepam Nasal Spray Versus Diazepam Rectal Gel (Diastat®)
Cause of deathNo reason given
Life of this trial
- Ran for about 1 year 1 month before it stopped.
- 78 participants enrolled.
- Results were posted on the registry 2 years 3 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Acorda Therapeutics
- Sponsor type
- Industry
- Conditions
- Refractory Epilepsy
- Interventions
- diazepam nasal spray; diazepam rectal gel
- Participants
- 78
- Sites
- 22
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.